Patents by Inventor Theo Moraes

Theo Moraes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200171085
    Abstract: A method of treating a respiratory viral infection in a mammal is provided. The method comprises administering to the mammal a therapeutically effective amount of alveolar-like macrophages, or an anti-viral factor produced by alveolar-like macrophages.
    Type: Application
    Filed: May 18, 2018
    Publication date: June 4, 2020
    Inventors: Theo Moraes, Martin Post, Yuchen Cen, Michael Litvack
  • Patent number: 9476049
    Abstract: Provided herein is a method of treating Respiratory Syncytial Virus (RSV) infection in a cell. The method involves administering the guanosine-rich oligonucleotide (GRO) AS 1411 (5?-GGTGGTGGTGG TTGTGGTGGTGGTGG-3?—also known as GR026B and AGRO100) to the cell.
    Type: Grant
    Filed: February 15, 2013
    Date of Patent: October 25, 2016
    Assignees: THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO, HOSPITAL FOR SICK CHILDREN
    Inventors: Richard George Hegele, Peter Mastrangelo, Theo Moraes
  • Publication number: 20150010618
    Abstract: Provided herein is a method of treating Respiratory Syncytial Virus (RSV) infection in a cell. The method involves administering the guanosine-rich oligonucleotide (GRO) AS 1411 (5?-GGTGGTGGTGG TTGTGGTGGTGGTGG-3?—also known as GR026B and AGRO100) to the cell.
    Type: Application
    Filed: February 15, 2013
    Publication date: January 8, 2015
    Applicant: University of Toronto
    Inventors: Richard George Hegele, Peter Mastrangelo, Theo Moraes